Orca Bio
About Orca Bio
Orca Bio is a late-stage biotechnology company focused on developing high-precision cell therapies for cancer and autoimmune diseases. Its investigational allogeneic T-cell programs leverage regulatory T cells to pursue safer, more effective outcomes. The company emphasizes precise manufacturing and a patient-centric mission to deliver the promise of cell therapy without compromise, with operations and pipeline exploration centered on biomedical advances in life sciences.
Recent News
Recent Deals
No recent deals for this company.